scholarly journals Analysis of the anti-apoptotic protein bcl-2 in oral squamous cell carcinoma

2007 ◽  
Vol 54 (3) ◽  
pp. 153-159
Author(s):  
Branka Popovic ◽  
Biljana Jekic ◽  
Ivana Novakovic ◽  
Jelena Milasin

Aim: The aim of this study was to analyze the presence of the anti-apoptotic protein bcl-2 in oral squamous cell carcinoma and determine its potential role in the development and progression of this type of tumor. Materials and methods: The expression of bcl-2 was determined in 28 paraffin blocks of oral squamous cell carcinoma using the immunohistochemical method. The percentage of the immuno-reactive cells in positively stained tumor regions was determined using the microscopic analysis and Ozaria software. Results: Positive immunohistochemical test was observed in 19 out of 28 samples (68%) as follows: in 11 samples there was a low (+), in four a moderate (++) and in the last four a high percentage (+++) of stained cells. In the group of patients at the low stage of the disease (T2), 50% of tumor samples showed bcl-2 protein expression whereas in the higher stages (T3 and T4) of positively stained samples, this percentage was 67%. There was a trend of an increasing number of cells with positive bcl-2 staining in the tumors of higher clinical stages but not the level of bcl-2 protein expression. Conclusion: Both parameters, the presence of bcl-2 staining and the percentage of cells with bcl-2 immunoexpression, may act as additional prognostic parameters that indicate an increased proliferative tumor potential.

2011 ◽  
Author(s):  
Rafael A. Madero ◽  
Chriss M. Lee ◽  
Riyaz M. Basha ◽  
Maen A. Abdelrahim ◽  
Cheryl H. Baker ◽  
...  

Head & Neck ◽  
2011 ◽  
Vol 34 (9) ◽  
pp. 1340-1345 ◽  
Author(s):  
Shih-Jung Cheng ◽  
Sang-Heng Kok ◽  
Jang-Jaer Lee ◽  
Mark Yen-Ping Kuo ◽  
Shih-Lung Cheng ◽  
...  

2010 ◽  
Vol 109 (5) ◽  
pp. 326-337 ◽  
Author(s):  
Tze-Ta Huang ◽  
Jeff Yi-Fu Chen ◽  
Chih-En Tseng ◽  
Yu-Chieh Su ◽  
Hsu-Chueh Ho ◽  
...  

2008 ◽  
Vol 87 (4) ◽  
pp. 401-406 ◽  
Author(s):  
S.-F. Yang ◽  
W.-E. Yang ◽  
H.-R. Chang ◽  
S.-C. Chu ◽  
Y.-S. Hsieh

Oral squamous cell carcinoma is the most common malignancy of the oral cavity, and treatment approaches are inadequate. Luteolin, a natural flavonoid compound, has been shown to have anti-tumorigenic properties on various types of tumors. Therefore, we hypothesized that luteolin has anti-tumorigenic properties for oral squamous cell carcinoma, and may provide effective chemotherapy. Results revealed that luteolin reduced the viability of SCC-4 cells and induced apoptosis by decreasing the expression of cyclin-dependent kinase (CDKs), cyclins, and phosphor- retinoblastoma (p-Rb) anti-apoptotic protein, but increased the expression of pro-apoptotic proteins and activated caspase 9 and 3, with a concomitant increase in the levels of cleaved poly-ADP-ribose polymerase (PARP). Combination treatment of luteolin with paclitaxel enhanced the cytotoxic effect of paclitaxel in SCC-4 cells, and continuous administration of luteolin suppressed the growth of xenograft tumors in nude mice. These results suggest that luteolin could be an effective chemotherapeutic agent for the treatment of oral squamous cell carcinoma.


2005 ◽  
Vol 1 (1) ◽  
pp. 114
Author(s):  
O. Kujan ◽  
R.J. Oliver ◽  
N. Ribeiro ◽  
R.T.F. Woodwards ◽  
N.S. Tbakker ◽  
...  

Oral Oncology ◽  
2010 ◽  
Vol 46 (3) ◽  
pp. 166-171 ◽  
Author(s):  
Marcilei Eliza Cavicchioli Buim ◽  
Silvia Vanessa Lourenço ◽  
Kátia Candido Carvalho ◽  
Roberta Cardim ◽  
Cláudia Pereira ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document